A possible intermediate step during apoptotic execution

Human cell : official journal of Human Cell Research Society

Volumn 15, Issue 1, 2002, Pages 43-51

  Tomioka, Masanori ^a,b   Sameshima, Masasumi ^a   Nakano, Hisako ^a   Kubo, Toshikazu ^c   Shinohora, Kunio ^d   Seyama, Yousuke ^b   Kawashima, Seiichi ^a   Toné, Shigenobu ^e  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CASPASE; DNA FRAGMENT; FAS ANTIGEN; LEUPEPTIN; MONOCLONAL ANTIBODY; PEPTIDE CHLOROMETHYL KETONE;

APOPTOSIS; ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; T CELL LEUKEMIA; THYMOMA;

AMINO ACID CHLOROMETHYL KETONES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CASPASES; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, T-CELL; LEUPEPTINS; THYMOMA; TUMOR CELLS, CULTURED;

EID: 0036516901     PISSN: 09147470     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2002.tb00098.x     Document Type: Article

References (40)

1. Ciechanover A: The ubiquitin‐proteasome proteolytic pathway. Cell 79: 13–21, 1994.
2. Scheffner M, Huibregtse J M, Vierstra R.D. et al: Ubiquitin‐protein ligase in the ubiquitination of p53. Cell 75: 495–505, 1993.
3. Deshaies R J, Chau V, Kirschner M: Ubiquitination of the G1 cyclin Cln2p by a Cdc34p‐dependent pathway. EMBO J. 14: 303–312, 1995.
4. Yaglom J, Linskens M H K, Sadis S. et al: p34Cdc28‐mediated control of Cln3 cyclin degradation. Mol. Cell. Biol. 15: 731–741, 1995.
5. Salama S R, Hendricks K B, Thorner J: G1 cyclin degradation: the PEST motif of yeast Cln2 is necessary, but not sufficient, for rapid protein turnover. Mol. Cell. Biol. 14: 7953–7966, 1994.
6. Seufert W, Futcher B, Jentsch S: Role of a ubiquitin‐conjugating enzyme in degradation of S‐ and M‐phase cyclins. Nature 373: 78–81, 1995.
7. Pagano M, Tarn S W, Theodoras A.M. et al: Role of the ubiquitin‐proteasome pathway in regulating abundance of the cyclin‐dependent kinase inhibitor p27. Science 269: 682–685, 1995.
8. Shinohara, K., Tomioka, M., Nakano, H., Toné, S., Ito, H., and Kawashima, S.:: Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317: 385–388, 1996.
9. Lopes, U. G., Erhardt, P., Yao, R, and Cooper, G. M.:: p53‐dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272: 12893–12896, 1997.
10. Drexler, H. C. A.:: Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94: 855–860, 1997.
11. Grimm, L. M., Goldberg, A. L., Poirier, G. G., Schwartz, L. M., and Osborne, B. A.:: Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15: 3835–3844, 1996.
12. Sadoul, R., Fernandez, P. A., Quiquerez, A. L., Martinou, I., Maki, M., Schroter, M., Becherer, J. D., Irmler, M., Tschopp, J., and Martinou, J. C.::Involvement of the proteasome in the programmed cell death of NGF‐deprived sympathetic neurons. EMBO J. 15: 3845–3852, 1996.
13. Chinnaiyan A M, Dixit V M: The cell‐death machine. Curr. Biol. 6: 555–562, 1996.
14. Miura M, Zhu H, Rotello R. et al: Induction of apoptosis in fibroblasts by IL‐1 beta‐converting enzyme, a mammalian homolog of the C. elegans cell death gene ced‐3. Cell 75: 653–660, 1993.
15. Oberhammer F A, Hochegger K, Froschl G. et al: Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J. Cell Biol. 126: 827–837, 1994.
16. Mashima T, Naito M, Fujita N. et al: Identification of actin as a substrate of ICE and an ICE‐like protease and involvement of an ICE‐like protease but not ICE in VP‐16‐induced U937 apoptosis. Biochem. Biophvs. Res. Commun. 217: 1185–1192, 1995.
17. Brancolini C, Benedetti M, Schneider C: Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE‐like proteases. EMBO J. 14: 5179–5190, 1995.
18. Enari M, Sakahira H, Yokoyama H. et al: A caspase‐activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43–50, 1998.
19. Tsubuki S, Saito Y, Tomioka M. et al: Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di‐Ieucine and tri‐leucine. J. Biochem. 119: 572–576, 1996.
20. Ito A, Takahashi R, Miura C. et al: Synthetic study of peptide aldehydes. Chem. Pharm. Bull 23: 3106–3113, 1975.
21. Nakano H, Shinohara K: X‐ray‐induced cell death: apoptosis and necrosis. Rad. Res 140: 1–9, 1994.
22. Sameshima M: The orientation of nucleus, nucleus‐associated body and protruding nucleolus in aggregating Dictyostelium discoideum. Exp. Cell Res 156: 341–350, 1985.
23. Lazebnik Y A, Kaufmann S H, Desnoyers S. et al: Cleavage of poly(ADP‐ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346–347, 1994.
24. McCarthy N J, Whyte M K B, Gilbert C.S. et al: Inhibition of Ced‐3/ICE‐related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl‐2 homologue Bak. J. Cell Biol 136: 215–227, 1997.
25. Xiang, J, Chao D T, Korsmeyer S J: BAX‐induced cell death may not require interleukin 1 beta‐converting enzyme‐like proteases. Proc. Natl. Acad. Sci. USA 93: 14559–14563, 1996.
26. Trapani J A, Jans D A, Jans P.J. et al: Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase‐dependent, but cell death is caspase‐independent. J. Biol. Chem 273: 27934–27938, 1998.
27. Nagata S: Apoptosis by death factor. Cell 88: 355–365, 1997.
28. Nicholson D W, Ali A, Thornberry N.A. et al: Identification and inhibition of the ICE/CED‐3 protease necessary for mammalian apoptosis. Nature 376: 3743, 1995.
29. Boldin M P, Goncharov T M., Goltsev Y.V. et al: Involvement of MACH, a novel MORT1/FADD‐interacting protease, in Fas/APO‐1‐ and TNF receptor‐induced cell death. Cell 85: 803–815, 1996.
30. Muzio M, Chinnaiyan A M., Kischkel F.C. et al: FLICE, a novel FADD‐homologous ICE/CED‐3‐like protease, is recruited to the CD95 (Fas/APO‐1) death‐inducing signaling complex. Cell 85: 817–827, 1996.
31. Lemaire C, Andreau K, Souvannavong V. et al: Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett 25: 266–270, 1998.
32. Ghibelli L, Maresca V, Coppola S. et al: Protease inhibitors block apoptosis at intermediate stages: a compared analysis of DNA fragmentation and apoptotic nuclear morphology. FEBS Lett 377: 9–14, 1995.
33. McGowan A J, Fernandes R S, Verhaegen S. et al: Zinc inhibits UV radiation‐induced apoptosis but fails to prevent subsequent cell death. Int. T. Rad. Biol 66: 343–349, 1994.
34. Stefanis L, Troy C M, Qi H. et al: Inhibitors of trypsin‐like serine proteases inhibit processing of the caspase Nedd‐2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J. Neurochem 69: 1425–1437, 1997.
35. Perry D K, Smyth M J, Stennicke H.R. et al: Zinc is a potent inhibitor of the apoptotic protease, caspase‐3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272: 18530–18533, 1997.
36. Kawahara A, Ohsawa Y, Matsumura H. et al: Caspase‐independent cell killing by Fas‐associated protein with death domain. J. Cell. Biol 143: 1353–1360, 1998.
37. Okada Y: Volume expression‐sensing outward‐rectifier C1‐channel: fresh start to the molecular identity and volume sensor. Am. J. Physiol. 273: C755–789. 1997.
38. Lang F, Uhlemann A C, Lepple‐Wienhues, A, et al: Cell volume regulatory mechanisms in apoptotic cell death. Hexz 24: 232–235, 1999.
39. Orlov S N, Dam T V, Tremblay J. et al: Apoptosis in vascular smooth muscle cells: role of cell shrinkage. Biochem. Biophys. Res. Commun 221: 708–715, 1996.
40. Bortner C D, Cidlowski J A: A necessary role for cell shrinkage in apoptosis. Biochem. Pharmacol 56: 1549–1559, 1998.